Showing results (701-710 of 828) with videos related to

Sort By:
Pageof 83
Breast Cancer Research and Treatment|April 3, 2013
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN Lynn Henry, Todd C Skaar, Jessica Dantzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500Jeffrey B Smerage, William E Barlow, Gabriel N Hortobagyi, et al.
Clinical Chemistry|October 5, 2012
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor MarkersGyörgy Sölétormos, Michael J Duffy, Daniel F Hayes, et al.
The Lancet. Psychiatry|November 21, 2021
Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal studyRuth Brauer, Basmah Alfageh, Joseph E Blais, et al.
Plos One|November 15, 2021
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancerElizabeth P Darga, Emily M Dolce, Fang Fang, et al.
Biosensors & Bioelectronics|February 14, 2006
Point-of-care biosensor systems for cancer diagnostics/prognosticsSteven A Soper, Kathlynn Brown, Andrew Ellington, et al.
Journal of the National Cancer Institute|December 7, 2006
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapyPeggy L Porter, William E Barlow, I-Tien Yeh, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 17, 2023
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)Mattias Bergqvist, Adrian Nordmark, Amy Williams, et al.
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
JCO Precision Oncology|January 12, 2023
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast CancerAfroditi Nanou, Jieling Miao, Frank A W Coumans, et al.
Pageof 83